Search
Press Releases
Search Archive:  

 

Saudi Arabia Pharma Industry Destined for Stupendous Upsurge

Jul 30, 2010
Share |
 
According to our new research report Saudi Arabian Healthcare Market Forecast to 2012, the pharmaceutical industry is one of the largest industries in Saudi Arab with immense potential. The industry has remained resilient against the global economic downturn and has continued to show noteworthy growth rate throughout. The pharmaceutical industry in Saudi Arabia was estimated to have reached around US$ 2.7 Billion in 2009. Various factors such as strong government support and rising penetration of health insurance will drive strong growth in the pharmaceutical industry.
 
We have done an extensive research and prudent analysis of the Saudi Arabian pharmaceutical industry in order to understand the factors that will continue to serve as growth driver for the pharmaceutical industry over the forecast period (2010-2012). We have identified that the country is highly dependent on the imported drugs, thereby giving room to the private players to set up their own manufacturing capacities in the country. Therefore, the pharmaceutical industry future remains pleasantly buoyant and it is expected that the industry will grow at a CAGR of around 10% during the period 2010-2012. The optimistic outlook for the growth is based on the fact that the burden of diseases has been increasing along with the rising awareness about healthcare among people.
 
Our research indicates that the Saudi Arabian healthcare industry shows immense potential of growth and is in the initial stages of development. There is a high demand for hospitals services and healthcare professionals in the country. Further, the medical devices industry is expected to witness substantial growth in coming years owing to strong investment by both the private and public sectors in setting up hospitals and clinics, which will create a strong demand for medical equipments and supplies.
 
Our report Saudi Arabian Healthcare Market Forecast to 2012 provides an extensive research, rational analysis and reliable statistics of the Saudi Arabian healthcare industry. It covers segment-wise break up and information of major emerging segments to give strategic insight into the market. The report has thoroughly examined the current market trends; industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years.

For more information visit: http://www.rncos.com/Report/IM173.htm

Related Press Releases:
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
» US Drug Spending – Reaching Soaring Rates
» Global Genetic Testing Market worth US$ 1.5 Billion, to Grow Significantly
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Check out our latest reports on What’s New page.
Not able to find the data you are looking for?
Consider requesting a
Custom Research Proposal.
Home | About Us | Careers | Request a Quote | Discounted Reports | Contact Us | Resources | Add URL | FAQ | Upcoming Reports
Copyright © 2012, RNCOS, 2002-2012
Phone : +91 (120) 4224700/01/02/03 Fax : +91 (120) 4224707